Memorial Sloan Kettering Cancer Center 11th Annual Hematology and Medical Oncology Board Review Contemporary Practice 2023
Format: 40 videos + 42 pdf, size: 6.84 GB
Course Audience: oncologist, hematologist
Overview:
Friday, March 10, 2023, 9:00 AM – Monday, March 13, 2023, 1:00 PM, Online, New York, NY
Specialties Specialties – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical OncologyOverviewThis four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Who Should Attend The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. Live Virtual Format This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course. Course registration includes access to an online syllabus, which includes PDFs of the slides and recorded videos of the faculty presentations.
Objectives- Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
- Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
- Prepare for ABIM examinations in medical oncology and hematology.
Friday, March 10, 2023SYLLABUS DISCLAIMER9:00AM – 9:05AMPlease note only the presentations from faculty that have given their consent will be available below.
Updated on 3/23/23 at 12:00 pm (EST)
MSK CME TERMS OF USE9:05AM – 9:10AMRelevant Financial Relationships9:10AM – 9:15AMTo view faculty disclosures,Colon Cancer9:15AM – 10:00AMMelanoma10:00AM – 10:45AMProstate Cancer10:45AM – 11:30AMKidney Cancer11:30AM – 12:15PMMesothelioma12:15PM – 12:30PMUrothelial Cancer1:15PM – 2:00PMTestis Cancer2:00PM – 2:45PMUterine/Cervix/Other GYN Cancers2:45PM – 3:30PMOvarian Cancer3:45PM – 4:30PMBreast Cancer: Surgery4:30PM – 5:00PMBreast Cancer: Radiation Therapy5:00PM – 5:30PMGenetics5:30PM – 6:00PMSaturday, March 11, 2023Small Cell Lung Cancer7:00AM – 7:30AMBreast Cancer: Adjuvant Therapy7:30AM – 8:30AMBreast Cancer: Advanced Disease8:30AM – 9:30AMBreast Cancer: Hormonal Therapy9:30AM – 10:00AMCarcinoma of Unknown Primary10:00AM – 10:30AMHepatocellular Cancer and Cholangiocarcinoma10:45AM – 11:30AMPancreatic and Neuroendocrine Cancer11:30AM – 12:15PMNon Small Cell Lung Cancer1:00PM – 2:00PMHead and Neck, Thyroid, Non-melanoma Skin Cancer2:00PM – 3:00PMAnal/Rectal Cancer3:00PM – 3:30PMEsophageal/Gastric Cancer3:45PM – 4:30PMCNS Tumors4:30PM – 5:00PMSarcoma5:00PM – 5:30PMInfectious Disease5:30PM – 6:00PMSunday, March 12, 2023Pharmacology I and II7:30AM – 9:00AMCAR T cells9:10AM – 10:10AMLow-Grade Non-Hodgkin Lymphoma (NHL)10:10AM – 10:40AMChronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)10:40AM – 11:10AMDiffuse Large B-Cell Lymphoma (DLBCL)/Mantle Cell Lymphoma (MCL)/Burkitt Lymohoma (BL)11:10AM – 12:10PMHodgkin Lymphoma (HL)/T Cell12:40PM – 1:40PMAuto/Allo1:40PM – 2:10PMAcute Lymphoblastic Leukemia (ALL)2:10PM – 2:40PMAcute Myeloid Leukemia (AML)2:40PM – 3:10PMMyelodysplastic/Myeloprofilerative Neoplasms (MDS/MPN)3:40PM – 4:40PMMyeloma/Amyloid4:40PM – 5:40PMMonday, March 13, 2023Approach to The Bleeding Patient8:05AM – 9:00AMThe Role of the New Direct Oral Anticoagulants in Practice9:00AM – 10:00AMThrombocytopenia, ITP and Beyond10:00AM – 11:00AMSickle Cell Disease, Thalassemia11:00AM – 12:00PM